|
|
|
Event Videos
|
https://pubmed.ncbi.nlm.nih.gov/35758506/ Autoimmune hepatitis J Pediatr Gastroenterol Nutr. 2022 Jun 27. Taisa Kohut 1, Amit Shah 2, Pierre Russo 3, Jennifer Panganiban 2 DOI: 10.1097/MPG.0000000000003534 Abstract Published on:
Jun-2022
|
https://pubmed.ncbi.nlm.nih.gov/35577029/ hepatoblastoma J Hepatol. 2022 May 13;S0168-8278(22)00275-6. Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults Published on:
May-2022
|
|
https://pubmed.ncbi.nlm.nih.gov/35758473/ NAFLD J Pediatr Gastroenterol Nutr. 2022 Jun 27. Νikolaos Gkiourtzis 1 2, Georgios Kalopitas 3, Andreas Vadarlis 3 4, Dimitra Rafailia Bakaloudi 2, Georgios Dionysopoulos 2, Evangelia Karanika 2, Eirini Tsekitsidi 2, Michail Chourdakis 2 Abstract Objectives: We conducted a systematic review and meta-analysis to provide a summary of the current literature about the efficacy of probiotics in pediatric non-alcoholic fatty liver disease (NAFLD). Published on:
Jun-2022
|
https://pubmed.ncbi.nlm.nih.gov/35581572/ NAFLD BMC Pediatr. 2022 May 17;22(1):286. Epidemiology and lifestyle survey of non-alcoholic fatty liver disease in school-age children and adolescents in Shenyang, Liaoning Guan Lin # 1, Zhang Xinhe # 1, Tian Haoyu 2, Jin Xing 1, Li Dan 1, Wang Ningning 1, Sun Jing 1, Wang Xue 1, Zeng Zilu 1, Li Yiling 3 Abstract Background: Non-alcoholic fatty liver disease (NAFLD) is diagnosed increasingly in children and adolescents. We aimed to investigate the prevalence and related influencing factors of NAFLD in school-aged children and adolescents in Shenyang, Liaoning Province. Furthermore, we analyzed the relationship between lifestyle and fatty liver. Published on:
May-2022
|
|
https://pubmed.ncbi.nlm.nih.gov/35149651/ hepatitis J Pediatr Gastroenterol Nutr. 2022 May 1;74(5):631-635. Severe Hepatitis in Pediatric Coronavirus Disease 2019 Swati Antala 1, Tamir Diamond 2, Larry K Kociolek 3, Amit A Shah 2, Catherine A Chapin 1 Abstract Published on:
May-2022
|
https://pubmed.ncbi.nlm.nih.gov/35582739/ Transplant Pediatr Transplant. 2022 May 17;e14322. Low post-transplant measles and varicella titers among pediatric liver transplant recipients: A 10-year single-center study Andrew Y J Liman 1, Laura J Wozniak 2, Annabelle de St Maurice 3, Gregory L Dunkel 2, Emy M Wanlass 2, Robert S Venick 2, Sue V McDiarmid 2 Abstract Background: Vaccine preventable illnesses are important sources of morbidity, mortality, and increased healthcare costs in pediatric LT recipients. Our aim was to measure the seroprevalence of antibodies to measles and VZV in this population. Published on:
May-2022
|
|
https://pubmed.ncbi.nlm.nih.gov/35442217/ J Pediatr Gastroenterol Nutr. 2022 May 30. PRESENTATION, MANAGEMENT AND OUTCOME OF CONGENITAL PORTOSYSTEMIC SHUNTS IN CHILDREN: THE BOSTON CHILDREN'S HOSPITAL EXPERIENCE Doaa M Fahmy 1 2, Paul D Mitchell 3, Maureen M Jonas 1 Abstract Objectives: Congenital portosystemic shunts (CPSS) are rare vascular malformations. We describe presentations, complications, associations, and outcomes of CPSS at Boston Children's Hospital (BCH). Methods: This was a retrospective review of children with CPSS at BCH from 2000-2020. Published on:
May-2022
|
https://pubmed.ncbi.nlm.nih.gov/35585255/ Eur J Pediatr. 2022 May 18. doi: 10.1007/s00431-022-04502-y. Online ahead of print. Nadia Roumeliotis 1 2 3 4, Eleanor Pullenayegum 5, Anna Taddio 5 6, Paula Rochon 7 8 9, Chris Parshuram 10 5 7 Abstract Published on:
May-2022
|
|
https://pubmed.ncbi.nlm.nih.gov/35560106/ NAFLD Hepatology. 2022 May 13. Nonalcoholic Fatty Liver Disease Risk and Histologic Severity are Associated with Genetic Polymorphisms in Children Nidhi P Goyal 1 2, Sara B Rosenthal 3, Chanod Nasamran 3, Cynthia A Behling 4, Jorge E Angeles 1, Mark H Fishbein 5, Kathryn E Harlow 6, Ajay K Jain 7, Jean P Molleston 8, Kimberly P Newton 1 2, Patricia Ugalde-Nicalo 1, A Xanthankos 9, Katherine Yates 10, Nicholas J Schork 11 12, Kathleen M Fisch 3, Jeffrey B Schwimmer 1 2, N. A. S. H. Clinical Research Network Abstract Published on:
May-2022
|
https://pubmed.ncbi.nlm.nih.gov/35591805/ hepatoblastoma Pediatr Blood Cancer. 2022 May 19;e29763. Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States Justin A Kahla 1, David A Siegel 2, Shifan Dai 3, Philip J Lupo 4 5 6, Jennifer H Foster 4 6, Michael E Scheurer 4 5 6, Andras A Heczey 4 6 7 Objective: Hepatoblastoma (HB) is the most common pediatric primary malignant liver tumor, its incidence has been increasing worldwide, but recent changes in incidence and outcomes with high population coverage are not well characterized. Published on:
May-2022
|
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
